Molina Healthcare (MOH) Stock Forecast & Price Target

$196.10 +0.48 (+0.25%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$195.52 -0.58 (-0.30%)

As of 07/31/2026 08:00 PM Eastern

Compare

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 17 Analyst Ratings

Sell
2

Hold
11

Buy
4

Based on 17 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 2 have given a sell rating, 11 have given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for MOH.

Consensus Price Target

$202.44
3.23% Upside

According to the 17 analysts' twelve-month price targets for Molina Healthcare, the average price target is $202.44. The highest price target for MOH is $286.00, while the lowest price target for MOH is $124.00. The average price target represents a forecasted upside of 3.23% from the current price of $196.10.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MOH Analyst Ratings Over Time

Type	Current Forecast 8/3/25 to 8/3/26	1 Month Ago 7/4/25 to 7/4/26	3 Months Ago 5/5/25 to 5/5/26	1 Year Ago 8/3/24 to 8/3/25
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	11 Hold rating(s)	13 Hold rating(s)	11 Hold rating(s)	9 Hold rating(s)
Sell	2 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$202.44	$184.81	$169.60	$244.55
Forecasted Upside	3.23% Upside	-19.36% Downside	-11.78% Downside	57.65% Upside
Consensus Rating	Hold	Hold	Hold	Hold

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Molina Healthcare Stock vs. The Competition

Type	Molina Healthcare	Healthcare Companies	Broader Market
Consensus Rating Score	2.18	2.31	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	3.23% Upside	926.54% Upside	13.49% Upside
News Sentiment Rating	Positive News See Recent MOH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/28/2026	Wells Fargo & Company 3 of 5 stars	Stephen Baxter 3 of 5 stars	Lower Target	Equal Weight	$235.00 ➝ $220.00	+10.07%
7/24/2026	Weiss Ratings 5 of 5 stars		Downgrade	Hold (C-) ➝ Sell (D+)
7/24/2026	Cantor Fitzgerald 5 of 5 stars	Sarah James 2 of 5 stars	Reiterated Rating	Neutral
7/24/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Underweight	$184.00 ➝ $180.00	-10.14%
7/24/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$250.00 ➝ $225.00	+15.42%
7/24/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Perform	$248.00 ➝ $218.00	+10.45%
7/23/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Strong-Buy
7/14/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$230.00	-5.06%
7/14/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$163.00 ➝ $230.00	-5.48%
7/13/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$286.00	+19.75%
Get the Latest News and Ratings for MOH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Molina Healthcare and its competitors with MarketBeat's FREE daily newsletter.
6/8/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$215.00	+10.89%
6/8/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Stansel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$169.00 ➝ $191.00	-2.77%
6/4/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$146.00 ➝ $167.00	-12.83%
5/22/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$180.00 ➝ $202.00	+11.67%
5/11/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$124.00 ➝ $163.00	-12.40%
4/29/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Underperform ➝ Buy	$250.00	+34.76%
4/24/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold	$129.00	-23.33%
2/11/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Fidel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$167.00 ➝ $124.00	+1.10%
4/9/2025	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Cassorla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Neutral
2/6/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raj Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Equal Weight	$345.00 ➝ $345.00	+19.20%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:26 AM ET.

Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 28, 2026. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

The current stock price is around $206, which reflects a significant range of performance over the past year, indicating potential for growth.
Molina Healthcare, Inc. reported earnings per share (EPS) of $1.51 for the latest quarter, exceeding analysts' expectations, which suggests strong operational performance.
The company has a solid current ratio of 1.68, indicating that it has sufficient assets to cover its short-term liabilities, which is a positive sign for financial stability.
Despite a slight decline in revenue year-over-year, the company generated $10.87 billion in revenue for the latest quarter, showing resilience in a competitive market.
With a debt-to-equity ratio of 0.95, Molina Healthcare, Inc. maintains a balanced approach to leveraging debt, which can be attractive to investors looking for stability.

Molina Healthcare
Bear Case

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

The company has a negative net margin of 0.02%, indicating that it is not currently profitable, which could raise concerns about its long-term viability.
Revenue has decreased by 4.8% compared to the previous year, suggesting potential challenges in maintaining growth and market share.
With a price-to-earnings ratio of -1,110.29, the stock may be perceived as overvalued, which could deter risk-averse investors.
Insider selling activity has been noted, with significant shares sold by key executives, which may signal a lack of confidence in the company's future performance.
The beta of 0.74 indicates lower volatility compared to the market, but it also suggests that the stock may not provide high returns during market upswings.

MOH Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $202.44, with a high forecast of $286.00 and a low forecast of $124.00.

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last twelve months. There are currently 2 sell ratings, 11 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.

According to analysts, Molina Healthcare's stock has a predicted upside of 3.23% based on their 12-month stock forecasts.

Over the previous 90 days, Molina Healthcare's stock had 2 upgrades and 1 downgrade by analysts.

Molina Healthcare has been rated by research analysts at Barclays, Cantor Fitzgerald, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, Truist Financial, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Molina Healthcare less than other "healthcare" companies. The consensus rating score for Molina Healthcare is 2.18 while the average consensus rating score for "healthcare" companies is 2.31. Learn more on how MOH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Molina Healthcare Recommendations

This page (NYSE:MOH) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Molina Healthcare (MOH) Stock Forecast & Price Target